In vitro, overexpressing TUG1 markedly inhibits cell proliferation by inducing cell cycle arrest and apoptosis in breast cancer cells, while silencing TUG1 leads to increased cell growth by promoting cell cycle progression and altering the expression of cyclinD1 and CDK4. Here, TUG1 is linked to breast carcinoma.